Incannex Healthcare (IXHL) Cash from Financing Activities (2023 - 2026)

Incannex Healthcare (IXHL) has reported Cash from Financing Activities for 4 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.

• Quarterly Cash from Financing Activities fell 39.18% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.4 million (up 600.7% YoY) and the FY2025 annual result came in at $21.4 million, changed N/A from the prior year.
• Cash from Financing Activities improved to $4.7 million in Q1 2026 per IXHL's latest filing, from $927000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for IXHL reached as high as $67.2 million in Q3 2025 and fell as low as -$73000.0 in Q1 2023.
• A 4-year average of $10.5 million and a median of $4.1 million in 2024 frame the typical range for Cash from Financing Activities.
• The largest YoY upside for Cash from Financing Activities was 129286.54% in 2025 against a maximum downside of 77.4% in 2025.
• Year by year, Cash from Financing Activities stood at -$32000.0 in 2023, then jumped by 12918.75% to $4.1 million in 2024, then tumbled by 77.4% to $927000.0 in 2025, then surged by 408.09% to $4.7 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $4.7 million, $927000.0, and $67.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.